Effects of chronic neuroleptic treatment on tyrosine hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology*; D003342:Corpus Striatum / Q000201:enzymology; D004298:Dopamine / Q000502:physiology*; D004361:Drug Tolerance; D006801:Humans; D007700:Kinetics; D008032:Limbic System / Q000201:enzymology; D009411:Nerve Endings / Q000187:drug effects*; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D014150:Antipsychotic Agents; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine